Tislelizumab plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients after Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study

Neoadjuvant Therapy Chemoradiotherapy
DOI: 10.1016/j.ijrobp.2024.07.1098 Publication Date: 2024-09-27T22:55:39Z